NCT06020183 is a NA clinical trial of Hybrid hyrax in Transverse Maxillary Deficiency, sponsored by Cairo University.

Who is sponsoring NCT06020183?

NCT06020183 is sponsored by Cairo University.

What drugs are being tested in NCT06020183?

Interventions in NCT06020183: Hybrid hyrax.

What condition does NCT06020183 study?

NCT06020183 studies Transverse Maxillary Deficiency.

Is NCT06020183 still recruiting?

NCT06020183 is currently active, enrolled. Last updated 21 June 2024.

Last reviewed 2024-06-21 · How we verify

NCT06020183

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Four Mini-screws Supported Hyrax for Maxillary Expansion in Early Adulthood

Active, enrolled NA Last updated 21 June 2024

What this trial tests

NA trial testing Hybrid hyrax in Transverse Maxillary Deficiency in 24 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 September 2023

Primary endpoint
2 July 2024

6 August 2024

Quick facts

Lead sponsor	Cairo University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	24
Start date	2 September 2023
Primary completion	2 July 2024
Estimated completion	6 August 2024
Sites	1 location across Egypt

Drugs / interventions tested

Hybrid hyrax

Conditions studied

Transverse Maxillary Deficiency — all drugs for Transverse Maxillary Deficiency →

Sponsor

Cairo University

Who can join

Adults 18 to 30, any sex, with Transverse Maxillary Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the Skeletal and Dento-alveolar expansion in adult patents using Four Mini-screws Supported Hyrax in compare with untreated control group.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Transverse Maxillary Deficiency

Currently open trials in the same condition.

NCT07086612 — Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) and Transverse Orthodontic Deficiency in Children · NA · recruiting
NCT07411092 — Three-dimensionally Printed Hyrax Versus Conventional Hyrax for Maxillary Arch Expansion in Adolescents · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06020183 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 21 June 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06020183.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing